Unusual Manifestation of Posttransplant Lymphoproliferative Disorder in the Esophagus

Transplantation Proceedings

Volumn 38, Issue 3, 2006, Pages 693-696

  Kranz, B ^a   Vester, U ^a   Becker, J ^a   Woltering, T ^a   Wingen, A M ^a   Paul, A ^a   Hoyer, P F ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; VIRUS DNA;

ACUTE GRAFT REJECTION; ARTICLE; B CELL LYMPHOMA; CASE REPORT; DISEASE COURSE; ENDOSCOPY; EPSTEIN BARR VIRUS; ESOPHAGUS TUMOR; HERPES VIRUS INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE UROPATHY; POSTOPERATIVE COMPLICATION; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; TONSILLITIS; TREATMENT RESPONSE;

ADULT; CHILD; ESOPHAGEAL NEOPLASMS; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 33646090160     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.01.075     Document Type: Article

References (7)

1. Dhamidharka V.R., Sullivan E.K., Stablein D.M., et al. Risk factors for posttransplant lymphoproliferative disorder (PTLD) in kidney transplantation. a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71 (2001) 1065
2. Penn I. De novo malignancies in pediatric organ transplant recipients. Pediatr Transpl 2 (1998) 56
3. Stevens S.J.C., Verschuuren E.A.M., Pronk I., et al. Frequent monitoring of Epstein-Barr virus load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97 (2001) 1165
4. Savoie A., Perpete C., Carpentier L., et al. Direct correlation between the load of Epstein-Barr virus infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83 (1994) 2715
5. Green M., Caccirelli T.V., Mazariegos G.V., et al. Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation 66 (1998) 1641
6. Shroff R., and Rees L. The post-transplant lymphoproliferative disorder-a literature review. Pediatr Nephrol 19 (2004) 369
7. Ho M., Miller G., Atchison R.W., et al. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions. The role of primary infection. J Infect Dis 152 (1985) 876